Zymeworks Stock (NASDAQ: ZYME) stock price, news, charts, stock research, profile.
You can purchase shares of Zymeworks (NASDAQ:ZYME) through any online brokerage.
Other companies in Zymeworks’s space includes: 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Upstream Bio (NASDAQ:UPB), Cogent Biosciences (NASDAQ:COGT) and Arcutis Biotherapeutics (NASDAQ:ARQT).
Zymeworks has a consensus price target of $20.67.
The stock price for Zymeworks (NASDAQ: ZYME) is $17.4 last updated November 12, 2024 at 4:00 PM EST.
There are no upcoming dividends for Zymeworks.
Zymeworks’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Zymeworks.
Zymeworks is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.